Microdosing is a practice of using sub-therapeutic doses to potentially obtain the benefits of a medication at lower doses
While it may not be the first choice for self-injection, it offers fast absorption comparable to the abdomen and is a valuable option in your site rotation schedule
Management of diuretic treatment: a challenge in the obese patient
Do not start, stop, change, or delay any medication, and do not delay seeking medical care, based on anything in this article
Two pivotal readouts are now public one in obesity with knee osteoarthritis, one in type 2 diabetes and seven additional Phase 3 readouts are expected before the end of 2026
however, the observed increased number of proliferating cell nuclear antigen (PCNA)-positive cells suggests an enhanced proliferative capacity following semaglutide therapy